首页> 美国卫生研究院文献>Annals of Oncology >Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled phase III trial of maintenance pemetrexed (H3E-MC-JMEN)

【2h】

Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled phase III trial of maintenance pemetrexed (H3E-MC-JMEN)

机译：确定目标非小细胞肺癌患者进行维持治疗：安慰剂对照的培美曲塞（H3E-MC-JMEN）维持III期临床试验的分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThis was a post hoc analysis of patients with non-squamous histology from a phase III maintenance pemetrexed study in advanced non-small cell lung cancer (NSCLC).

机译：背景这是一项针对晚期非小细胞肺癌（NSCLC）的III期维持培美曲塞研究的非鳞状组织学患者的事后分析。

著录项

期刊名称 Annals of Oncology
作者
C. Obasaju; L. Bowman; P. Wang; W. Shen; K. B. Winfree; E. N. Smyth; M. E. Boye; W. John; T. Brodowicz; C. P. Belani;
展开▼
作者单位

展开▼
年(卷),期 -1(24),6
年度 -1
页码 1534–1542
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
lung cancer symptom scale maintenance therapy non-squamous NSCLC patient-reported symptoms pemetrexed survival;

机译：肺癌症状量表;维持治疗;非鳞状非小细胞肺癌;患者报告的症状;培美曲塞;生存;

相似文献

外文文献
中文文献
专利

1. Identifying the target NSCLC patient for maintenance therapy: An analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)? [J] . ObasajuC., BowmanL., WangP., Annals of oncology: official journal of the European Society for Medical Oncology . 2013,第6期

机译：确定目标非小细胞肺癌患者进行维持治疗：安慰剂对照的培美曲塞（H3E-MC-JMEN）维持III期临床试验的分析？
2. Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies [J] . Langer Corey J., Paz-Ares Luis G., Wozniak Antoinette J., Clinical lung cancer . 2017,第5期

机译：高级非鳞状NSCLC患者植物磷酸甲虫 - 顺铂和培养疗法的安全分析：回顾性分析2期二期研究
3. First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial [J] . Boye Mark, Wang Xin, Srimuninnimit Vichien, Clinical lung cancer . 2016,第2期

机译：一线培美曲塞加顺铂联合吉非替尼维持治疗与吉非替尼单药治疗在患有局部晚期或转移性非鳞状非小细胞肺癌的东亚非吸烟患者中的生活质量来自一项随机III期试验
4. EFFECT OF TARGETED PULSED ELECTROMAGNETIC FIELD THERAPY ON CANINE POST-OPERATIVE HEMILAMINECTOMY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL [C] . ACVS Veterinary Symposium . 2018

机译：靶向脉冲电磁场治疗对犬术后血栓切除术的影响：双盲，随机，安慰剂对照临床试验
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized Phase 3 Trial [O] . Jin Hyoung Kang, Myung-Ju Ahn, Dong-Wan Kim, 2016

机译：一线培美曲塞-顺铂再加吉非替尼维持治疗与吉非替尼单药治疗在晚期非鳞状非小细胞肺癌韩国患者中的耐受性和结果：一项随机3期试验的事后描述性亚组分析
7. 143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial. [O] . Gautschi, O, Li, Q, Matter-Walstra, K, 2016

机译：143PD：贝伐单抗和培美曲塞与单独使用培美曲塞相比，作为晚期非鳞状非小细胞肺癌患者的维持治疗：SAKK19 / 09扩大试验的结果。

Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled phase III trial of maintenance pemetrexed (H3E-MC-JMEN)

摘要

著录项

相似文献

相关主题

期刊订阅